Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

被引：0

作者：

Chatzikonstantinou, Thomas ^{[1
]}

Scarfo, Lydia ^{[2
,3
]}

Minga, Eva ^{[1
]}

Karakatsoulis, Georgios ^{[1
]}

Chamou, Dimitra ^{[1
]}

Kotaskova, Jana ^{[4
,5
,6
]}

Iacoboni, Gloria ^{[7
]}

Demosthenous, Christos ^{[8
,9
]}

Albi, Elisa ^{[2
]}

Alcoceba, Miguel ^{[10
,11
]}

Al-Shemari, Salem ^{[12
]}

Aurran-Schleinitz, Therese ^{[13
]}

Bacchiarri, Francesca ^{[14
]}

Chatzileontiadou, Sofia ^{[15
]}

Collado, Rosa ^{[16
]}

Davis, Zadie ^{[17
]}

de Deus Santos, Marcos Daniel ^{[18
]}

Dimou, Maria ^{[19
]}

Dmitrieva, Elena ^{[20
]}

Donaldson, David ^{[21
]}

Dos Santos, Gimena ^{[22
]}

Dreta, Barbara ^{[23
]}

Efstathopoulou, Maria ^{[24
]}

El-Ashwah, Shaimaa ^{[25
]}

Enrico, Alicia ^{[26
]}

Frygier, Andrzej ^{[27
]}

Galimberti, Sara ^{[28
]}

Galitzia, Andrea ^{[29
]}

Gimeno, Eva ^{[30
]}

Guarente, Valerio ^{[31
,32
,33
]}

Guieze, Romain ^{[34
]}

Harrop, Sean ^{[35
]}

Hatzimichael, Eleftheria ^{[36
]}

Herishanu, Yair ^{[37
,38
]}

Hernandez-Rivas, Jose-angel ^{[39
]}

Jaksic, Ozren ^{[40
]}

Kalicinska, Elzbieta ^{[41
]}

Laribi, Kamel ^{[42
]}

Karakus, Volkan ^{[43
]}

Kater, Arnon P. ^{[44
]}

Kho, Bonnie ^{[45
]}

Kislova, Maria ^{[20
]}

Konstantinou, Eliana ^{[46
]}

Koren-Michowitz, Maya ^{[47
,48
]}

Kotsianidis, Ioannis ^{[49
]}

Kubova, Zuzana ^{[50
,51
]}

Labrador, Jorge ^{[52
]}

Lad, Deepesh ^{[53
]}

Laurenti, Luca ^{[54
,55
]}

Longval, Thomas ^{[56
]}

机构：

[1] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece

[2] Univ Vita Salute San Raffaele, Milan, Italy

[3] IRCCS Osped San Raffaele, Milan, Italy

[4] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic

[5] Masaryk Univ, Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic

[6] Masaryk Univ, Fac Med, Brno, Czech Republic

[7] Univ Hosp Vall dHebron, Dept Hematol, Barcelona, Spain

[8] G Papanicolaou Hosp, Hematol Dept, Thessaloniki, Greece

[9] G Papanicolaou Hosp, HCT Unit, Thessaloniki, Greece

[10] Univ Hosp Salamanca HUS IBSAL, Dept Haematol, CIBERONC CB16 12 00233, Salamanca, Spain

[11] Canc Res Ctr CIC IBMCC USAL CSIC, Salamanca, Spain

[12] Kuwait Univ, Fac Med, Dept Med, Kuwait, Kuwait

[13] Inst Paoli Calmettes, Dept Hematooncol, Marseille, France

[14] Univ Siena, Div Hematol, Siena, Italy

[15] AUTH, AHEPA Hosp, Dept Internal Med 1, Hematol Unit, Thessaloniki, Greece

[16] Fdn Invest Hosp Gen Univ Valencia, Consorcio Hosp Gen Univ Valencia, Serv Hematol, Valencia, Spain

[17] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England

[18] Univ Fed Espirito St, Internal Med Dept, Vila Velha, ES, Brazil

[19] Natl & Kapodistrian Univ Athens, Laikon Gen Hosp, Dept Hematol & Bone Marrow Transplantat, Athens, Greece

[20] SP Botkins City Hosp, Dept Hematol Oncol & Chemotherapy, Moscow, Russia

[21] Belfast City Hosp, Clin Haematol, Belfast, North Ireland

[22] Hosp Clin Montevideo, Montevideo, Uruguay

[23] Univ Hosp Ctr Zagreb, Dept Internal Med, Div Hematol, Zagreb, Croatia

[24] Athens Med Ctr Psychikon Branch, Dept Haematol, Athens, Greece

[25] Mansoura Univ, Oncol Ctr, Mansoura, Egypt

[26] Hosp Italiano La Plata, La Plata, Buenos Aires, Argentina

[27] Hull York Med Sch, Kingston Upon Hull, England

[28] Univ Pisa, Dept Clin & Expt Med, Sect Hematol, Pisa, Italy

[29] Osped Oncol A Businco, ARNAS G Brotzu, Hematol & Stem Cell Transplantat Unit, Cagliari, Italy

[30] Hosp Mar, Dept Hematol, Barcelona, Spain

[31] Univ Perugia, Inst Hematol, Perugia, Italy

[32] Univ Perugia, Ctr Hematooncol Res, Perugia, Italy

[33] Santa Maria Misericordia Hosp, Perugia, Italy

[34] Estaing Univ Hosp, Dept Hematol & Cell Therapy, Clermont Ferrand, France

[35] Univ Melbourne, St Vincents Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[36] Univ Ioannina, Fac Med, Sch Hlth Sci, Dept Haematol, Ioannina, Greece

[37] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Hematol, Tel Aviv, Israel

[38] Tel Aviv Univ, Fac Med, Tel Aviv, Israel

[39] Infanta Leonor Univ Hosp, Pathol Dept, Madrid, Spain

[40] Univ Hosp Dubrava, Dept Hematol, Zagreb, Croatia

[41] Wroclaw Med Univ, Dept & Clin Hematol Blood Neoplasms & Bone Marrow, Wroclaw, Poland

[42] Ctr Hosp Le Mans, Dept Hematol, Le Mans, France

[43] Antalya Training & Res Hosp, Antalya, Turkiye

[44] Univ Amsterdam, Amsterdam Univ Med Ctr, Canc Ctr Amsterdam, Dept Hematol, Amsterdam, Netherlands

[45] Pamela Youde Nethersole Eastern Hosp, Dept Med, Chai Wan, Hong Kong, Peoples R China

[46] Univ Athens, Laikon Gen Hosp, Dept Haematol, Athens, Greece

[47] Shamir Med Ctr, Dept Hematol, Zerifin, Israel

[48] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel

[49] Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Hematol, Alexandroupolis, Greece

[50] Palacky Univ, Fac Med & Dent, Dept Hematooncol, Olomouc, Czech Republic

来源：

HEMASPHERE | 2024年 / 8卷 / 09期

关键词：

VENETOCLAX; RITUXIMAB;

D O I：

10.1002/hem3.70004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：7

共 50 条

[31] Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China
Xu, Zhenshu
Zhang, Jinyan
Wu, Shunquan
Zheng, Zhihong
Chen, Zhizhe
Zhan, Rong
ONCOLOGY LETTERS, 2013, 5 (04) : 1266 - 1272
[32] Second Primary Malignancies (SPMs) in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With the Combination of a Targeted Agent With an Antibody in 4 Phase 2 Trials of the German CLL Study Group (GCLLSG)
Goergen, Ellinor
von Tresckow, Julia
Giza, Adam
Robrecht, Sandra
Fink, Anna-Maria
Fischer, Kirsten
Al-Sawaf, Othman
Fuerstenau, Moritz
Simon, Florian
Kutsch, Nadine
Nieper, Pascal
Tausch, Eugen
Ritgen, Matthias
Boettcher, Sebastian
Kreuzer, Karl-Anton
Stilgenbauer, Stephan
Langerbeins, Petra
Eichhorst, Barbara
Hallek, Michael
Cramer, Paula
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S354 - S355
[33] Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience
Innocenti, Idanna
Fresa, Alberto
Tomasso, Annamaria
Tarnani, Michela
De Padua, Laura
Benintende, Giulia
Pasquale, Raffaella
Galli, Eugenio
Morelli, Francesca
Giannarelli, Diana
Autore, Francesco
Laurenti, Luca
CANCERS, 2023, 15 (23)
[34] miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study
Duroux-Richard, Isabelle
Gagez, Anne-Laure
Alaterre, Elina
Letestu, Remi
Khalifa, Olfa
Jorgensen, Christian
Lepretre, Stephane
Tchernonog, Emmanuelle
Moreaux, Jerome
Cartron, Guillaume
Apparailly, Florence
FRONTIERS IN IMMUNOLOGY, 2022, 13
[35] Clinical outcomes among patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who received treatment with a covalent BTK and BCL2 inhibitor in the United States: a real-world database study
Eyre, Toby A.
Hess, Lisa M.
Sugihara, Tomoko
He, Dan
Khanal, Manoj
Pagel, John M.
Walgren, Richard A.
B. Abada, Paolo
Konig, Heiko
Roeker, Lindsey E.
Mato, Anthony
LEUKEMIA & LYMPHOMA, 2023, 64 (05) : 1005 - 1016
[36] Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial
Herling, Carmen D.
Cymbalista, Florence
Gross-Ophoff-Mueller, Carolin
Bahlo, Jasmin
Robrecht, Sandra
Langerbeins, Petra
Fink, Anna-Maria
Al-Sawaf, Othman
Busch, Raymonde
Porcher, Raphael
Cazin, Bruno
Dreyfus, Brigitte
Ibach, Stefan
Lepretre, Stephane
Fischer, Kirsten
Kaiser, Florian
Eichhorst, Barbara
Wentner, Clemens-Martin
Hoechstetter, Manuela A.
Doehner, Hartmut
Leblond, Veronique
Kneba, Michael
Letestu, Remi
Boettcher, Sebastian
Stilgenbauer, Stephan
Hallek, Michael
Levy, Vincent
LEUKEMIA, 2020, 34 (08) : 2038 - 2050
[37] Modulation of CD20 Antigen Expression After Rituximab Treatment: A Retrospective Study in Patients With Chronic Lymphocytic Leukemia
D'Auria, Fiorella
Guariglia, Roberto
Villani, Oreste
Mansueto, Giovanna
Grieco, Vitina
Zonno, Antonia
Bianchino, Gabriella
Di Giovannantonio, Luigina
Vita, Giulia
Musto, Pellegrino
CLINICAL THERAPEUTICS, 2010, 32 (11) : 1911 - 1916
[38] IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study
Rotbain, Emelie Curovic
Frederiksen, Henrik
Hjalgrim, Henrik
Rostgaard, Klaus
Egholm, Gudrun Jakubsdottir
Zahedi, Banafsheh
Poulsen, Christian Bjorn
Enggard, Lisbeth
da Cunha-Bang, Caspar
Niemann, Carsten Utoft
HAEMATOLOGICA, 2020, 105 (06) : 1621 - 1629
[39] Final results of EFC6663: A multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia
Lanasa, Mark C.
Andritsos, Leslie
Brown, Jennifer R.
Gabrilove, Janice
Caligaris-Cappio, Federico
Ghia, Paolo
Larson, Richard A.
Kipps, Thomas J.
Leblond, Veronique
Milligan, Donald W.
Janssens, Ann
Johnson, Amy J.
Heerema, Nyla A.
Buehler, Andreas
Stilgenbauer, Stephan
Devin, Jeanne
Hallek, Michael
Byrd, John C.
Grever, Michael R.
LEUKEMIA RESEARCH, 2015, 39 (05) : 495 - 500
[40] Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study
Visentin, Andrea
Mauro, Francesca Romana
Catania, Gioachino
Fresa, Alberto
Vitale, Candida
Sanna, Alessandro
Mattiello, Veronica
Cibien, Francesca
Sportoletti, Paolo
Gentile, Massimo
Rigolin, Gian Matteo
Quaglia, Francesca Maria
Murru, Roberta
Gozzetti, Alessandro
Molica, Stefano
Marchetti, Monia
Pravato, Stefano
Angotzi, Francesco
Cellini, Alessandro
Scarfo, Lydia
Reda, Gianluigi
Coscia, Marta
Laurenti, Luca
Ghia, Paolo
Foa, Robin
Cuneo, Antonio
Trentin, Livio
FRONTIERS IN ONCOLOGY, 2022, 12

← 1 2 3 4 5 →